Skip to content

Functional Electrical Stimulation (FES) Exercise Training in Hemodialysis Patients

Efficacy of Functional Electrical Stimulation Exercise Training in Hemodialysis Patients

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01956214
Enrollment
9
Registered
2013-10-08
Start date
2012-12-31
Completion date
2016-11-30
Last updated
2017-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complication of Dialysis

Keywords

hemodialysis, exercise, electrical stimulation

Brief summary

Both strength training and endurance exercise training are commonly prescribed to improve strength and function in patients with physical limitations caused by chronic disease or disability including chronic kidney disease (CKD). Individuals with CKD often have low physical function due to progressive declines in the performance of their kidneys. The low physical function leads to physical inactivity, which exacerbates these functional declines and promotes cardiovascular disease and bone disorders. In addition, severe functional limitations in some patients prevent them from exercising at a great enough intensity to provide significant benefits. As a result, alternative strategies are needed to maximize the benefits of exercise while decreasing injury risk.

Detailed description

Both strength training and endurance exercise training are commonly prescribed to improve strength and function in patients with physical limitations caused by chronic disease or disability including chronic kidney disease (CKD). Individuals with CKD often have low physical function due to progressive declines in the performance of their kidneys. The low physical function leads to physical inactivity, which exacerbates these functional declines and promotes cardiovascular disease and bone disorders. In addition, severe functional limitations in some patients prevent them from exercising at a great enough intensity to provide significant benefits. As a result, alternative strategies are needed to maximize the benefits of exercise while decreasing injury risk. A new form of exercise, functional electrical stimulation (FES)-enhanced cycling has been shown to increase muscle size and strength in patients with severe disabilities, particularly spinal cord injury (SCI). It is based on the application of electrical stimulation to the nerves that innervate the paralyzed weak muscles in order to generate muscle contraction. FES has been used to stimulate leg muscles to pedal a cycle or to enable partial weight-supported walking as an activity based rehabilitation therapy. FES cycling involves exercising using a motor-assisted cycle coupled with electrical stimulation to up to five muscles in the leg. There are well-documented benefits of FES-induced exercise in SCI patients including clinically significant increases in muscle mass, blood flow, bone density, and bowel and bladder function. A few pilot studies have also demonstrated that FES therapy has the potential to improve function in other disabled populations, including chronic heart failure and stroke patients. However, its effects in other populations with significant physical impairments, including CKD patients, have yet to be established. The objective of the proposed research is to evaluate the effects of FES-cycling training on measures related to physical function, quality of life (QOL), heart disease, and bone health in patients with renal failure receiving dialysis therapy.

Interventions

OTHERFES Exercise

receive FES while exercising

OTHERMock FES Exercise

participants will receive Mock FES

Sponsors

University of Illinois at Urbana-Champaign
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
31 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. Age 31-85 years 2. Must receive hemodialysis treatment at least 3 days per week 3. Must be willing to be randomized to the control or FES-cycle groups 4. Must receive medical clearance from a Nephrologist at their dialysis clinic to participate 5. Must have evidence of impaired mobility on the FES Screening Form, attached. The FES Screening Form inclusion criterion consist of a questionnaire of five tasks with a relative difficulty scale for the completion of each task. Participants will be included in the study if they indicate some or more difficulty at any task on the questionnaire.

Exclusion criteria

1. On dialysis treatment for less than 3 months. 2. Body weight of greater than 400 pounds. (weight limitations on the DXA table) 3. Unstable angina, recent (less than 3 months) myocardial infarction or stroke (these conditions may not enable the patient to tolerate the proposed exercise training). 4. Implanted electronic pacing or defibrillation device, vagus nerve stimulator, or unstable vital signs.(the safety of electrical stimulation under these conditions is not known). 5. Metal implants underneath or near the muscle groups which are to be stimulated. 6. Pregnancy (the safety of stimulation during pregnancy is not known) - a section on the ICD has been created for women to initial to indicate they are NOT pregnant or planning on becoming pregnant over the course of the study. 7. Lower limb amputation. On the PAR-Q form, if the participant answers YES to the question: Has your doctor ever said that you have a heart condition and that you should only do physical activity recommended by a doctor?, they will be excluded from the study. We will also use answers on the Medical History Form to help us evaluate the

Design outcomes

Primary

MeasureTime frameDescription
physical functionThree monthsmuscle strength, functional fitness testing, shuttle walk test, balance and gait kinematics

Other

MeasureTime frameDescription
quality of life (QOL)three monthsquestinnaire
heart diseasethree monthsarterial and cardiac measures
bone healththree monthsDXA scan for bone mineral density, body composition, vascular calcification

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026